Roche Diagnostics is aiming at 15 percent share of India’s in-vitro diagnostics market in the next two years said Shravan Subramanyam, managing director for Roche Diagnostics for India & Neighboring Markets.
“We are also seeing consolidation of our customers, that is labs, and we would like to access tier II and tier III cities and rural markets through them and get a larger piece of the diagnostics market,” Subramanyam added.
Currently the company sells devices and equipment to labs and hospitals and is mainly in the business-to-business space. For the next five years, the company will focus on women’s health, non communicable diseases: diabetes, cardio vascular diseases, cancer and wellness segments. “But as India still has a very high burden of infectious diseases, we will continue to be in the space of infectious diseases,” Subramanyam affirmed.
Last updated: December 26th, 2025
